NASDAQ:EARS Auris Medical (EARS) Stock Price, News & Analysis → Gold Mania (From Stansberry Research) (Ad) Free EARS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.60▼$1.6650-Day Range$2.25▼$3.2752-Week Range$0.73▼$6.60Volume29,769 shsAverage Volume3.10 million shsMarket Capitalization$18.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media Get Auris Medical alerts: Email Address Ad Allegiance GoldCould Your Accounts Be Frozen?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit About Auris Medical Stock (NASDAQ:EARS)Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through Switzerland and Australia geographical segments. Its product pipeline includes AM-125, AM-201, AM301, Sonsuvi, and Keyzilen. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.Read More Ad Allegiance GoldCould Your Accounts Be Frozen?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit EARS Stock News HeadlinesMay 2, 2024 | msn.comBest Medical Alert Systems for Seniors With Hearing Loss, Tested and ReviewedMay 1, 2024 | forbes.comChronic Ear Infections Could Delay Children’s Language DevelopmentMay 4, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.April 19, 2024 | yahoo.comHow to Relieve Ear PressureApril 16, 2024 | npr.orgThe Open Ears ProjectApril 11, 2024 | msn.comHow to Pop Your Ears on a Plane, According to Medical ExpertsApril 4, 2024 | msn.comCan Humans Get Ear Mites From a Pet?April 4, 2024 | msn.comSouth Euclid pediatrician testing app to diagnose ear infection using a smart phoneMay 4, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.April 1, 2024 | msn.comResearchers Create An Appropriate Lifelike Replica Of An Adult Human EarMarch 13, 2024 | msn.comRevolutionary Smartphone App Diagnoses Ear Infections in ChildrenMarch 10, 2024 | yahoo.comWhy Pimples Form in the Ear—And How to Get Rid of ThemMarch 7, 2024 | markets.businessinsider.comEssential Guide for Alleviating Itchy Ears, with Expert Insights from Dr. Emily McMahanFebruary 28, 2024 | msn.comCandida Auris Fungus Infection: Symptoms, Spread, TreatmentFebruary 24, 2024 | msn.comEar-Tok: Doctors warn of the risks of TikTok ear-cleaning trendFebruary 18, 2024 | msn.comAre Your Ears Ringing? 10 Ways to Manage TinnitusFebruary 15, 2024 | msn.comEar doctor reveals the weirdest things he's ever yanked outFebruary 14, 2024 | msn.comNew ear tube procedure for children can be done in five minutesFebruary 11, 2024 | msn.com'No common symptoms' for deadly fungal disease sweeping US poses 'challenges' for expertsFebruary 8, 2024 | msn.comMap shows spread of deadly fungal disease across US killing one in three patientsFebruary 8, 2024 | msn.comThe deadly fungal disease C. auris spreading across the US explained - symptoms, treatment and outbreaksFebruary 6, 2024 | msn.comWhat to know about Seattle's potentially deadly fungus outbreakFebruary 6, 2024 | msn.comDeadly 'Candida auris' fungal infection spreading rapidly across US with 60% death rateFebruary 6, 2024 | nytimes.comWhat’s the Best Way to Clean Your Ears?February 6, 2024 | msn.comCandida Auris Outbreak: Know About This Fatal Fungal Infection Spreading Like Wildfire in the USAFebruary 5, 2024 | msn.comDeadly Fungal Infection Spreading to New Parts of U.S., CDC WarnsFebruary 5, 2024 | msn.com'Nightmare' deadly fungal infection with 60% fatality rate spreading rapidly across USSee More Headlines Receive EARS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Auris Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/11/2017Today5/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:EARS CUSIPN/A CIK1601936 Webwww.aurismedical.com Phone(441) 295-5950FaxN/AEmployees132,200Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio3.83 Quick Ratio3.83 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.57 per share Price / Book1.04Miscellaneous Outstanding Shares11,417,000Free FloatN/AMarket Cap$18.72 million OptionableNot Optionable Beta1.17 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesThomas MeyerChairman & Chief Executive OfficerElmar SchärliChief Financial OfficerSamuel A. WicklineChief Scientific OfficerAndrea VondraskovaMedical DirectorKey CompetitorsVincerx PharmaNASDAQ:VINCAvalo TherapeuticsNASDAQ:AVTXTalpheraNASDAQ:TLPHNeuroSense TherapeuticsNASDAQ:NRSNOrgenesisNASDAQ:ORGSView All Competitors EARS Stock Analysis - Frequently Asked Questions How were Auris Medical's earnings last quarter? Auris Medical Holding Ltd. (NASDAQ:EARS) announced its quarterly earnings data on Thursday, May, 11th. The biotechnology company reported ($4.40) EPS for the quarter, missing analysts' consensus estimates of ($2.80) by $1.60. When did Auris Medical's stock split? Auris Medical's stock reverse split on the morning of Wednesday, May 1st 2019. The 1-20 reverse split was announced on Tuesday, April 30th 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 30th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Auris Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Auris Medical investors own include Helios and Matheson Analytics (HMNY), Anavex Life Sciences (AVXL), OPKO Health (OPK), Rigel Pharmaceuticals (RIGL), Flexion Therapeutics (FLXN), Novavax (NVAX), Iconix Brand Group (ICON), Onconova Therapeutics (ONTX) and Nabriva Therapeutics (NBRV). This page (NASDAQ:EARS) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe only AI company you should be looking atBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Auris Medical Holding Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
